METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin

Clinical trial NCT05504252 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05504252
Sponsor: University Hospital, Akershus
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Adenocarcinoma Mucinous Adenocarcinoma Signet Ring Cell Adenocarcinoma

Start date: 2022-10-05
Primary completion: 2028-01-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.